The first session will take place on Saturday, May 30, 2026. Access to this initial session will be completely free, allowing participants to experience the course structure, methodology, and practical research environment before making a final enrollment decision. To facilitate this process, the enrollment deadline has been extended until June 4, 2026, allowing attendees to participate in the first session before deciding whether to formally enroll in the full program. After the first session, formal enrollment will be mandatory, and access to subsequent sessions, materials, recordings, datasets, and activities will be restricted exclusively to registered participants. For the first session, participants will work directly with a real-world clinical research database provided by microscopIA. Before the session, please: Verify the quality and stability of your internet connection Download JMP and activate the official free trial Download the attached database and workspace file Connect to the session on time During this first session, participants will learn from zero using a real-world clinical research dataset within a fully practical and publication-oriented environment. The database corresponds to a microscopIA research project conducted in collaboration with Dr. Francisco Camargo Assis, a Colombian intensivist. The project evaluated whether significant differences exist in admission patterns and clinical outcomes among pregnant women from urban and rural areas admitted to critical care units. Currently, it is in the late stages of peer review and awaiting a final editorial decision in a PubMed-indexed journal specializing in obstetric anesthesia and critical care. Session Schedule— Saturday, May 30, 2026 Latin America and the Caribbean Argentina: 11:00 AM – 2:00 PM Bolivia: 10:00 AM – 1:00 PM Brazil (Brasília/São Paulo): 11:00 AM – 2:00 PM Brazil (Amazonas): 10:00 AM – 1:00 PM Chile: 10:00 AM – 1:00 PM Colombia: 9:00 AM – 12:00 PM Costa Rica: 8:00 AM – 11:00 AM Cuba: 10:00 AM – 1:00 PM Dominican Republic: 10:00 AM – 1:00 PM Ecuador: 9:00 AM – 12:00 PM El Salvador: 8:00 AM – 11:00 AM Guatemala: 8:00 AM – 11:00 AM Haiti: 10:00 AM – 1:00 PM Honduras: 8:00 AM – 11:00 AM Jamaica: 9:00 AM – 12:00 PM Mexico City, Mexico: 8:00 AM – 11:00 AM Nicaragua: 8:00 AM – 11:00 AM Panama: 9:00 AM – 12:00 PM Paraguay: 10:00 AM – 1:00 PM Peru: 9:00 AM – 12:00 PM Puerto Rico: 10:00 AM – 1:00 PM Trinidad and Tobago: 10:00 AM – 1:00 PM Uruguay: 11:00 AM – 2:00 PM Venezuela: 10:00 AM – 1:00 PM United States New York, USA: 10:00 AM – 1:00 PM Los Angeles, USA: 7:00 AM – 10:00 AM

*Course Coordinator Jorge Racedo holds a bachelor’s degree in Biomedical Engineering from Universidad de Los Andes (Bogotá, Colombia) and has participated in clinical and research training programs at Mayo Clinic (Rochester, MN), Imperial College London (London, England), and MD Anderson Cancer Center (Houston, TX). He currently serves as General Manager of microscopIA and leads its research group. *Teaching Assistant Bryan N. Forero received his MD degree from Universidad de Ciencias Aplicadas y Ambientales (Bogotá, Colombia). He is currently an Internal Medicine resident at Fundación Universitaria San Martín (Bogotá, Colombia) and serves as an associate researcher at microscopIA since 2025. *Senior Collaborators Dr. Joseph L. Nates is an internationally recognized critical care physician, educator, and healthcare leader with decades of experience in intensive care medicine, oncologic critical care, sepsis management, and multidisciplinary clinical operations. He has served in major leadership roles at the The University of Texas MD Anderson Cancer Center, (Houston, TX) where he contributed to the development of advanced critical care programs integrating clinical excellence, research, education, and systems-based management for critically ill oncologic patients. Throughout his career, Dr. Nates has been actively involved in international collaborations, medical education, guideline development, and mentorship of physicians and researchers across multiple countries, becoming a respected figure in critical care medicine and healthcare leadership. He will work directly supervising some review papers which topics are critical care medicine. Dr. Agamenón Quintero Villarreal is a specialist in Critical Care and intensive medicine, currently serving as theHead of the Department of Critical Care at IMAT Oncomédica in Colombia. He is a recognized leader in intensive care medicine in Latin America and has held multiple leadership positions, including Past President of the Colombian Association of Critical Care and Intensive Care Medicine (AMCI), Vice President of the Pan-American and Iberian Federation of Critical Care and Intensive Care Societies (FEPIMCTI), and President of the Colombian Association of Scientific Societies. He is also an associated researcher at microscopIA, leading its research division on critical care medicine. As a senior collaborator for this course, he will support the allocation of experienced clinicians and other healthcare professionals to participate in manuscript development and mentorship, strengthening networking and collaborative research opportunities for attendees.

Online sessions: step-by-step guidance on data management. Real-world publication project: preparing a manuscript (review paper or meta-analysis) for submission to a PubMed-indexed journal and participating as an author.

This course is designed as a fully hands-on and experiential workshop rather than a traditional theoretical course. Therefore, there is no fixed syllabus or conventional lecture-based structure. All attendees are expected to have JMP (software) installed and to download the first database before the course begins. From the very first session, participants will actively reproduce the instructors’ demonstrations and learn how to process, analyze, and interpret real data in real time. The course follows a “learning by doing” methodology. Instead of traditional didactic or magistral lectures, participants will progressively acquire the necessary statistical/epidemiology/data science/health economics and research knowledge through practical application during the sessions. Concepts and analytical methods will be introduced according to the needs of each project and dataset, ensuring that learning remains dynamic, flexible, practical, and directly relevant to research activities in clinical medicine and public health.

The course is self-contained: activities related to data management are completed during scheduled sessions, with no work assigned outside class. For the manuscript preparation, groups are encouraged to self-govern, so the workload intensity depends on the group’s internal consensus on progress.

Unlike traditional theoretical workshops or lecture-based courses, this program is fully experiential and project-oriented. Participants learn by actively working on real research activities from the very beginning of the course. The program integrates: Real database analysis Manuscript development Journal-oriented writing Translational research design Networking with clinicians and researchers Exposure to real publication workflows Mentorship and collaborative scientific work Rather than focusing primarily on theory, the course emphasizes practical immersion in the real-world ecosystem of biomedical research and scientific publication.

Yes. Participants who successfully complete the course requirements, including the analysis of a database in the last session and the submission of a manuscript by the end of the course, will receive an official certificate issued by microscopIA. microscopIA is recognized by the Ministry of Science, Technology and Innovation of Colombia under Call 948 of 2021.

By the end of the course, participants will have: The ability to process research datasets Practical understanding of statistical workflows Experience interpreting numerical and graphical outputs Familiarity with publication-oriented research operations Exposure to collaborative scientific workflows Scientific Production Experience A certificate for their curriculum Preparing either a review paper or meta-analysis (only available for postdocs and MD/DO graduates) to be submitted to a PubMed-indexed journal. microscopIA will: Coordinate manuscript submission Include active participants as co-authors Cover any open-access publication fees associated with the submission process 📌 Publication remains contingent upon the editorial and peer-review decision of the target journal.

Designed for beginners and advanced participants alike One of the central objectives of this program is accessibility. The course does not require previous training in statistics, epidemiology, or data science. All theoretical concepts required to understand and conduct the analyses will be explained progressively during the live practical sessions. Participants will learn: What each statistical analysis means Why specific methods are used How to interpret numerical outputs How to interpret graphical results How to identify meaningful findings How to translate analytical results into scientific conclusions The educational approach prioritizes understanding through direct execution and supervised practice.

Every session is structured around active participation. Participants will work directly with databases and analytical workflows commonly used in: Retrospective studies Prospective studies Clinical trials Translational research Health economics Public health investigations Healthcare systems analyses Under supervision, participants will learn how to: Process and organize clinical datasets Conduct statistical analyses Generate tables and figures Interpret outputs Prepare manuscript-ready materials Organize supplementary files Structure scientific reports The program aims to reproduce the workflow of a real clinical research team.

From theory to execution Many research training programs remain heavily theoretical and provide limited exposure to real operational research workflows. This program was designed differently. The objective is not only to teach concepts, but to ensure participants finish the course with: Practical analytical skills Experience working within research teams Familiarity with publication preparation Exposure to translational scientific collaboration Confidence processing and interpreting clinical data independently

This program is intended for: Medical students Biomedical sciences students Biomedical and clinical engineering students General physicians Clinical specialists Residents or fellows in clinical or surgical residencies Nurses Epidemiologists and professionals in public health Engineers Master’s students PhD students Individuals interested in clinical or translational research No advanced mathematical or statistical background is required.

Beginning during the first weekend, participants will be organized into collaborative research teams of five (review papers) or ten (meta.analyses) members. Each group will develop a manuscript focused on either Clinical/Surgical Medicine, Biomedical Engineering, Healthcare Innovation, Public Health, or Translational research. Throughout the course, teams will progressively: Select and refine a topic Organize references Develop manuscript sections Prepare figures and tables Structure the scientific narrative Finalize a submission-ready manuscript

Beyond the academic content of the course, participants will have the opportunity to build meaningful and long-lasting professional connections. During the development of the manuscripts attendees will collaborate not only with fellow course participants but also with invited expert clinicians and healthcare professionals affiliated with major medical associations and recognized academic institutions both in Colombia and abroad. These experts, who have established track records in research and clinical leadership, may participate as senior authors and mentors in selected projects. In addition, microscopIA maintains an active collaborative network of clinicians and other professionals from multiple medical specialties who participate in a wide range of ongoing research projects. This multidisciplinary environment allows participants to interact with professionals from diverse clinical and academic backgrounds, fostering future collaborations and mentorship opportunities.

Attendance is not mandatory. We understand that many participants are clinicians or medical students with demanding schedules; therefore, all sessions will be recorded and made available exclusively to registered course participants through microscopIA’s educational platform. Access to recordings, course materials, and platform activities will only be granted to enrolled attendees. Attendance will not affect course outcomes or certification eligibility. However, we strongly encourage participants to attend the live sessions whenever possible. Active participation provides valuable opportunities for discussion, mentorship, networking, and direct interaction with the instructors and research team. In addition, microscopIA actively recruits motivated students and professionals for its research group. Participation during the course allows us to better understand attendees’ interests, commitment, and academic potential, which may open opportunities for future collaboration and research involvement.

Yes. Attendance is not mandatory, and groups are expected to work at their own pace, negotiating internal deadlines realistically based on members’ schedules.

Fees: Colombian citizen or resident: $300.000 Colombian pesos (COP) International citizen: 150 United States Dollars (USD) Payment Methods: Card Apple Pay Google Pay WeChat Pay Amazon Pay Pix Klarna Bancolombia direct transference (only for Colombia) International payments are processed securely through Stripe, one of the world’s leading online payment platforms. microscopIA does not store credit or debit card information on its servers. Stripe uses encrypted and industry-standard security protocols to help protect transactions and payment data.

As part of microscopIA’s commitment to expanding access to practical clinical research education in Colombia, two special discount pathways are currently available exclusively for Colombian nationals. Through the leadership and coordination efforts of María Fernanda Cárdenas, medical student at Universidad de Antioquia, microscopIA became one of the sponsors of the Pre-Social Service Congress in Colombia organized by the National Association of Interns and Residents (ANIR), which will take place on May 22–23, 2026. In parallel, as former president of the Colombian National Medical Student Association, María Fernanda also promoted a national support initiative allowing Colombian students to access the program under a reduced tuition model. As part of these collaborative efforts, all Colombian citizens and residents has a final fees of $300.000 Colombian pesos (COP).

Yes! All participants are expected to deliver a manuscript in English and complete submission under microscopIA.

After participants deliver their manuscripts, microscopIA may continue working with the authors during the following two weeks to further improve the manuscript and support the journal submission process, provided that the submitted work is considered sufficiently rigorous, high-quality, and potentially suitable for peer-reviewed publication. This additional support may include: scientific and editorial revisions, structural and methodological feedback, formatting assistance, and language editing. We understand that English may not be the first language of many participants, and that some attendees may still be developing confidence in academic scientific writing. Therefore, the microscopIA team may provide additional guidance to improve clarity, grammar, readability, and overall manuscript quality to help maximize the likelihood of successful submission and peer-review consideration. However, the primary responsibility for manuscript preparation, revisions, responsiveness, teamwork, and delivery quality remains with the participant teams. Additional editorial and submission support from microscopIA is not automatically guaranteed and will only be provided to teams that deliver manuscripts meeting acceptable academic, scientific, and professional standards.

Each group is expected to self-manage its workflow and internal deadlines. However, participants must comply with the following key milestones established by microscopIA: June 7, 2026: Deadline to report the selected topic to microscopIA. June 14, 2026: microscopIA will assign the target journal for each project and provide the author guidelines and manuscript preparation requirements. June 27, 2026: Final deadline to submit the completed manuscript to microscopIA for editorial review, language editing, and submission support. July 5, 2026: Official manuscript submission day. microscopIA will coordinate the final submission process together with the authors. Teams will be invited to participate in a 30-minute-videocall during which the manuscript submission to the target journal will be completed collaboratively. We strongly encourage teams to organize their work efficiently, distribute responsibilities early, and maintain consistent communication throughout the course to ensure timely completion of the manuscript.

If a manuscript does not meet the minimum academic, scientific, or editorial standards expected by microscopIA, the authors will be formally notified and provided with feedback regarding the main limitations identified in the submission. A new deadline for revision and resubmission will then be established, allowing the team an additional opportunity to improve the manuscript. Participants are expected to address the concerns raised and substantially strengthen the quality of the work before the revised submission. The final revision attempt must be submitted before July 1, 2026. If, after the final attempt, the manuscript still does not meet the minimum standards required for scientific rigor, methodological quality, professionalism, and publication suitability, the manuscript will not be accepted for further editorial support or journal submission through microscopIA.

Participants are encouraged to organize teams according to shared academic and professional interests. For example, attendees interested in cardiology, oncology, surgery, radiology, public health, or other specialties are encouraged to collaborate on projects aligned with their future career goals and areas of interest. This approach allows participants to develop research projects that are genuinely relevant to their intended professional trajectory. This may be particularly valuable for clinicians with established careers, as well as for medical students and physicians preparing applications for clinical or surgical residency programs. Teams will be free to choose the topic of their review paper. microscopIA will provide guidance to help ensure that the selected topic remains academically relevant, methodologically appropriate, and potentially suitable for publication. If a team experiences difficulty identifying a topic, the microscopIA will actively support participants in exploring promising and publishable research directions. However, topics for meta-analyses will be selected and supervised by experts collaborating with microscopIA to ensure methodological rigor, feasibility, and alignment with current scientific priorities.

To maintain scientific rigor and academic quality, all review paper topics must be grounded in evidence-based medicine and established scientific methodology. microscopIA expects participants to select topics that are clinically relevant, methodologically sound, and meaningful for healthcare practice, surgical decision-making, public health, or healthcare systems. Projects should address objective scientific questions with clear academic and real-world value. All proposed manuscripts must follow scientifically accepted research standards and maintain a neutral, evidence-based, and academically rigorous perspective throughout the research and writing process. Topics primarily driven by ideological, political, activist, or non-evidence-based frameworks will not be accepted. The course is intended to prioritize scientific integrity, methodological rigor, critical analysis of the literature, and clinically or operationally relevant healthcare questions. The publication process carries an important ethical responsibility toward the scientific community, healthcare systems, and patients worldwide, particularly vulnerable populations disproportionately affected by limitations in healthcare access and evidence generation. For this reason, microscopIA expects high-quality academic work, professionalism, intellectual honesty, and strong commitment from all participants throughout the program. The following topics are not allowed: Gender studies and feminism Abortion promotion Planetary health and one health frameworks Race critical theory Climate change Human rights for animals and plants Smart cities and 15-minute-cities Insect-based diets Vaccination hesitancy Any other related to non-scientific activism, non-professional advocacy movements, NGO-supported activism, or financially biased by third parties

microscopIA encourages participants to use the manuscript development process as an opportunity to expand their professional, clinical, and academic networks. Each team may propose up to two senior external experts to participate as collaborators or senior authors. However, external contributors may only be incorporated into a project after prior review and approval by microscopIA. Before submitting a request, teams are expected to deliberate internally and realistically evaluate potential candidates within their professional or academic networks. Proposed collaborators should be individuals whose expertise, experience, and professional trajectory can meaningfully strengthen the scientific, clinical, methodological, or translational value of the manuscript. microscopIA particularly encourages teams to consider inviting leading clinicians, surgeons, healthcare decision-makers, innovators, or professionals occupying high-responsibility roles within healthcare systems or institutions, as these collaborations may provide valuable long-term networking and mentorship opportunities. This may be especially beneficial for medical students and junior physicians preparing applications for residency, fellowship, research, or international academic opportunities. Beyond the scientific value of the manuscript itself, microscopIA views the review paper or meta-analysis development process as an opportunity for participants to establish meaningful professional relationships and expand their academic network with potential future collaborators. If a team does not have identified experts within its own network, microscopIA may support participants in exploring and evaluating potential collaborators whose expertise appropriately aligns with the project objectives. In addition, microscopIA will support teams in ensuring appropriate academic coordination and professional recognition throughout the collaboration process whenever external experts are incorporated into the project. Once suitable candidates have been identified, the team must submit a formal request to microscopIA. microscopIA will then determine whether proceeding with the invitation is appropriate, considering the project’s academic objectives, methodological requirements, feasibility, publication potential, and professional alignment. Eligibility is limited to clinicians and healthcare or public health professionals with demonstrated real-world experience in clinical practice, healthcare delivery, healthcare management, innovation, industry, public health implementation, or other operational clinical or surgical environments. Professionals whose career trajectory has been exclusively limited to university-based academic settings, without meaningful involvement in clinical, operational, governmental, healthcare-system, or industry contexts, will not be considered eligible. This requirement is intended to ensure that invited collaborators contribute practical, translational, and decision-relevant perspectives to the research process. To preserve scientific neutrality, methodological rigor, and the academic focus of the course, invited collaborators must not be associated with political activism, partisan organizations, NGOs primarily engaged in ideological advocacy, or non-scientific activist activities. Teams interested in incorporating external experts must notify microscopIA no later than June 7, 2026, to allow adequate evaluation and approval before any formal invitation is sent.

The final publication decision always depends on the editorial team and peer reviewers of the target journal. For this reason, all teams are expected to commit fully to producing a high-quality manuscript with strong scientific rigor and academic standards. To maximize the probability of publication, microscopIA has established a structured submission workflow involving up to three sequential journal submissions. If the manuscript is rejected by the first journal, the team will have the opportunity to revise and improve the manuscript based on reviewer feedback before submission to a second journal. If the manuscript is also rejected by the second journal, a final submission may be made to a third and last journal. If the manuscript is rejected after the third submission, the workflow will conclude, and the manuscript will be returned to the authors for their independent disposition and future decisions. microscopIA will no longer provide continued editorial assistance, manuscript editing, or support related to publication fees. Subsequent revisions and resubmissions will be primarily managed by the author team. Please note that, due to research integrity standards and publication regulations, a manuscript cannot be submitted simultaneously to more than one journal at the same time. Sequential submission is a standard ethical requirement in academic publishing and must be strictly respected by all participants.

PubMed-indexed journals are the target for manuscript submission.

Teams are welcome to suggest potential journals for manuscript submission. However, the final decision regarding journal selection will be made primarily by microscopIA. The microscopIA research team will objectively evaluate and select the most appropriate PubMed-indexed journal based on the manuscript’s characteristics and its likelihood of successful acceptance. This decision process is guided by several academic and editorial considerations, including: Relevance of the topic to the journal’s scope and current editorial interests Scientific quality and methodological strength of the manuscript Novelty and clinical relevance of the review Compatibility with the journal’s audience and publication priorities Estimated probability of peer-review acceptance Manuscript structure, length, and formatting requirements Some research topics may align more strongly with the editorial priorities of specific journals, increasing the likelihood of successful publication. For this reason, journal selection will be conducted strategically to maximize the academic impact and publication potential of each manuscript.

The timeline from manuscript submission to potential acceptance varies significantly depending on the target journal, the peer-review process, and editorial decisions. In most cases, an initial editorial response may take several weeks to several months. After the manuscript is delivered to microscopIA, the team will spend approximately two weeks performing editorial revisions, formatting adjustments, language improvements, and preparing the manuscript for submission to the selected journal. Once submitted, the manuscript may undergo multiple stages, including: Editorial screening Peer review Requests for revisions Final editorial decision As a result, the total process from initial submission to potential publication may range from a few months to over a year, depending on reviewer timelines, revision requirements, and the number of journals involved in the workflow.

Potentially yes. However, participation in meta-analysis projects is restricted to teams composed exclusively of MD/DO holders, physicians with completed medical training, or postdoctoral-level professionals with sufficient academic and methodological experience. Due to the substantially higher methodological complexity, statistical demands, and risk of critical scientific errors associated with meta-analyses, students, junior trainees, and professionals without advanced clinical or postdoctoral training are unfortunately not eligible to lead or participate in these projects within the course framework. Meta-analyses require advanced understanding of: evidence-based medicine systematic literature evaluation bias assessment statistical interpretation clinical reasoning and publication standards For this reason, microscopIA limits these projects to participants with sufficiently advanced professional and academic backgrounds to ensure scientific rigor and publication quality. In addition, all meta-analysis topics, methodological structures, and supervision pathways will be determined and overseen by experts collaborating with microscopIA. Final approval for participation in a meta-analysis project remains subject to evaluation by the microscopIA team.

Beyond the core course activities in data management, interpretation, and manuscript development, microscopIA may invite selected participants to engage in advanced academic and translational research activities. These opportunities are not part of the standard course requirements and are reserved for participants who demonstrate outstanding performance during the sessions or who have a strong prior academic, clinical, methodological, or professional trajectory. Selection may consider: quality of participation during the course, methodological reasoning, scientific maturity, professionalism, responsiveness, leadership, teamwork, previous research experience, clinical or technical background, and alignment with ongoing microscopIA research priorities. Selected participants may be invited to participate in activities such as designing randomized controlled trials for pharmaceutical interventions, developing trial protocols for artificial intelligence–based diagnostic or clinical decision-support platforms, translating healthcare research concepts into public policy proposals, evaluating implementation-oriented research strategies, or supporting publication-oriented research protocols currently under development by microscopIA. These advanced activities are intended to expose selected participants to the broader ecosystem of modern biomedical research, clinical innovation, translational science, and healthcare decision-making. They may also provide opportunities to contribute to protocol refinement, literature review, methodological development, manuscript preparation, or future journal submissions. Participation in these initiatives is completely optional and is not required for successful course completion or certification eligibility. Final selection and assignment to any advanced activity will remain at the discretion of microscopIA, based on participant performance, trajectory, project needs, and compatibility with the organization’s research standards and collaborative culture.

microscopIA actively welcomes motivated individuals interested in developing high-level biomedical research skills within a collaborative, multidisciplinary, and internationally oriented environment. There are no nationality restrictions for joining the microscopIA research network, and international applicants are welcome to apply. Requirements vary according to the applicant’s academic and professional background. Applicants from programs primarily focused on social sciences or disciplines without a strong biomedical, technical, clinical, engineering, or quantitative methodological structure are not eligible. microscopIA does support interdisciplinary collaboration; however, this usually involves professionals who already possess a biomedical or technical foundation alongside additional expertise in areas such as economics, law, business, healthcare policy, or public administration through dual training pathways or substantial professional experience. *For Undergraduate and Graduate Students Applicants must: Be enrolled in a degree program with a strong biomedical, clinical, engineering, computational, or quantitative scientific foundation, including medicine, nursing, engineering, data science, biology, statistics, epidemiology, public health (curriculum subject to evaluation), or related disciplines Commit up to 5 hours per week for semi-supervised research activities Be capable of working independently without fixed schedules, with performance evaluated primarily through deadlines, project quality, and completion Be fully fluent in both English and Spanish Hold a minimum GPA of 4.0/5.0 (or equivalent) Submit two reference letters to the microscopIA admission committee Demonstrate integrity, professionalism, academic responsibility, communication skills, and genuine interest in scientific research *For General Physicians and Engineers Applicants must: Commit up to 5 hours per week to research activities Be fully fluent in English and Spanish Hold a minimum GPA of 4.0/5.0 (or equivalent) Submit two reference letters to the microscopIA admission committee Demonstrate leadership, organizational capacity, and the ability to supervise or mentor junior researchers Be willing to progressively specialize in a technical research area selected jointly with microscopIA Potential specialization pathways include: Epidemiology Health economics Geospatial analysis Data science and biostatistics Artificial intelligence applications in healthcare Mathematical modelling Bioinformatics Advanced healthcare analytics Other methodological and translational research areas *For Experienced Specialist Physicians Specialist physicians are expected to contribute primarily through clinical collaboration, strategic guidance, mentorship, and access to real-world clinical environments and datasets. Requirements include: Commitment to collaborate with the microscopIA network on at least: One case report every three months, and One larger study per semester Active participation in securing institutional permissions, ethics committee approvals, and facilitating access to clinical data when applicable Collaboration with research teams during study development, methodological planning, and manuscript preparation Commitment to support members of the microscopIA network with reference letters and microscopIA's certificate, as appropriate. There are no language restrictions for specialist physicians. *Selection Process Admission into microscopIA is selective and based not only on academic qualifications, but also on compatibility with the organization’s collaborative culture, scientific standards, professionalism, and long-term research vision. Applications are reviewed collectively by the research team. Some applicants may be invited to interviews to evaluate communication skills, leadership potential, professionalism, commitment, and compatibility with the group dynamic. Once accepted, researchers will also be incorporated into the official researcher database recognized by the Colombian Ministry of Science, Technology and Innovation as part of microscopIA’s institutional research structure. Participants who complete this course and are interested in applying to the microscopIA research network are encouraged to submit their application through the “Global Health” section.

This course represents one of the main pathways through which microscopIA identifies highly motivated, academically strong, and professionally aligned candidates for potential incorporation into its research network. Participants who demonstrate outstanding performance, professionalism, leadership, scientific rigor, strong methodological reasoning, responsiveness, and collaborative skills throughout the course may be considered for future participation within microscopIA as associate researchers or collaborators. Particular attention will be given to teams and authors who consistently deliver high-quality academic work, demonstrate strong commitment during the sessions, and produce projects or manuscripts with meaningful scientific and publication potential. The course also allows the microscopIA team to better evaluate participants’ work ethic, communication skills, capacity to work under research-oriented environments, and compatibility with the organization’s collaborative culture and long-term objectives. In addition, beginning in July 2026, microscopIA is expected to open new internal research opportunities across multiple areas, including clinical research, global health, epidemiology, artificial intelligence applications in healthcare, health economics, implementation science, and translational biomedical research. Participants selected to join the network may have the opportunity to apply for projects that best align with their academic interests, technical background, and long-term professional goals. However, enrollment in the course does not guarantee admission into the microscopIA research network. Selection remains competitive and will depend on participant performance, trajectory, professionalism, and alignment with the scientific standards and operational culture of the organization.

Yes, microscopIA covers any publication fees for manuscripts that are active in the publication workflow.

No— do not worry! The course has been designed to minimize additional financial barriers for participants. For statistical analysis activities, participants will use JMP. Attendees may install and activate the official free trial version directly through the software provider. In addition, microscopIA will fund one Rayyan subscription per team to support systematic review and literature screening activities during the course.

For reference management, microscopIA advises using Zotero or Mendeley, both free. For literature review and screening, microscopIA will fund one Rayyan subscription per team to support systematic review.

microscopIA is the legal owner or manager of the datasets. Manuscripts are co-owned by microscopIA and the authors, but microscopIA remains the primary decision-maker.

June 4, 2026. You can attend the first session for free while deciding.

The instructions and access details required to register for the online sessions will be sent on May 20, 2026. Participants will also receive: a certificate of enrollment confirming their participation in the course, access instructions for the educational platform, and a survey requesting authorship-related information for the review paper or research activities. The survey will collect details such as: full author name, institutional affiliations to be reported, email address, phone number, and other publication-related information necessary for manuscript preparation and academic coordination. Participants are encouraged to complete the survey carefully to help ensure accurate authorship records and smooth coordination throughout the course and manuscript development process.

The next microscopIA course will be “Writing a Case Report”, an experiential research workshop focused on the development, preparation, and submission of real clinical case reports. During the course, participants will receive a clinical case provided by one of the microscopIA collaborators. Before the course begins, informed consent procedures and the corresponding institutional permissions will already be coordinated with the patients and healthcare facilities involved. This workshop is designed as a highly practical, publication-oriented, and mentorship-based experience. Participants will work in teams of three members to develop a complete case report manuscript under direct supervision and mentorship from a microscopIA researcher. Unlike the current course, this program will not include formal online lecture sessions. Instead, participants will receive personalized guidance, editorial feedback, methodological support, and direct mentorship throughout the manuscript development and submission process. All case reports developed during the course are expected to proceed through the microscopIA publication workflow and be submitted to PubMed-indexed journals. For this reason, the workshop places strong emphasis on scientific writing quality, responsiveness, professionalism, teamwork, and the ability to work under publication-oriented academic standards. All manuscripts will be written in English. Therefore, participants are required to be fully fluent in both English and Spanish to ensure effective communication, manuscript preparation, literature interpretation, and collaboration throughout the course. Registration for the course is expected to open on June 15, 2026. Course details Course: Writing a Case Report Dates: June 22 – July 17, 2026 Format: Experiential workshop with direct mentorship Team structure: Groups of three participants Fee: 850 United States Dollars (USD)

Participants can continue collaborating only if they are admitted into the microscopIA network.

No. Most activities developed during the course do not require additional ethics committee approval. Review papers and meta-analyses are based on previously published scientific literature and therefore do not involve direct interaction with human participants, animals, or prospective clinical interventions. In addition, some of the datasets used during the course were specifically designed for educational and training purposes. When real-world datasets are utilized, they originate from ongoing or previously approved microscopIA projects in which the corresponding institutional permissions, ethics committee approvals, data-use authorizations, and regulatory requirements have already been secured when applicable. Participants will not be expected to independently obtain ethics approval for the standard educational activities conducted within the course framework. However, microscopIA will also introduce participants to the ethical principles, regulatory responsibilities, and research-governance considerations involved in biomedical and clinical research development.

Yes. Teams must provide a statement acknowledging AI use. AI may only be used to improve text quality or grammar; authors remain fully responsible for the intellectual content and scientific work. AI Usage Statement (Template): “The authors acknowledge the use of artificial intelligence (AI) tools to assist in improving the clarity, grammar, and readability of the text. All intellectual content, data interpretation, and conclusions presented in this manuscript are the sole responsibility of the authors.”

As attendance is not mandatory, there is no issue with missing online sessions, which are recorded and available for all course participants. However, manuscript preparation must be coordinated with the team. No exceptions will be made regarding manuscript contributions, and any absence or unavailability must be managed internally within the team.

Groups must self-govern and address any conflicts internally. microscopIA expects all participants to maintain cordial and professional behavior; disrespectful behavior will not be tolerated. If internal attempts do not resolve the issue, microscopIA will intervene. In such cases, all the participants involved may no longer take part in manuscript preparation but can continue attending the online sessions.

Recommendation letters are not automatically provided. They are only available for participants who are formally admitted as associate researchers in the microscopIA network and maintain active collaboration and demonstrated academic performance.

Yes. The online sessions are conducted in Spanish. However, the manuscript must be written in English. Participants who are not fully fluent in English are encouraged to use translators, but it is the team’s responsibility to deliver a high-quality manuscript. If the manuscript does not meet minimum quality standards, the team will be given a final opportunity to submit an enhanced version.

Yes, but participants are expected to understand the online sessions conducted in Spanish, as most team members are Spanish speakers. Fluency in Spanish is required to effectively collaborate with the team, while the manuscript must still be written in English. Teams remain responsible for delivering a high-quality manuscript that meets publication standards.